SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001420720-23-000033
Filing Date
2023-06-27
Accepted
2023-06-27 08:00:55
Documents
14
Period of Report
2023-06-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20230622x8k.htm   iXBRL 8-K 43720
2 EX-99 ibio-20230622xex99.htm EX-99 10520
  Complete submission text file 0001420720-23-000033.txt   184431

Data Files

Seq Description Document Type Size
3 EX-101.SCH ibio-20230622.xsd EX-101.SCH 3943
4 EX-101.DEF ibio-20230622_def.xml EX-101.DEF 3263
5 EX-101.LAB ibio-20230622_lab.xml EX-101.LAB 13480
6 EX-101.PRE ibio-20230622_pre.xml EX-101.PRE 10083
8 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20230622x8k_htm.xml XML 4621
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 231044002
SIC: 2834 Pharmaceutical Preparations